Patient-centred care in type 2 diabetes mellitus - Key aspects of PDM-ProValue are reflected in the 2018 ADA/EASD consensus report.
In 2018, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) published a consensus report on the management of hyperglycaemia in type 2 diabetes, recommending, amongst others, a patient-centred decision cycle to prevent complications and optimise quality of life. The PDM-ProValue study program which focused on the assessment of integrated personalised diabetes management provided evidence for the efficacy of its implementation. In this comparative review, we identified the standardised decision cycle as well as individualised patient assessment as the overarching elements of the ADA/EASD consensus report and the PDM-ProValue study. The decision cycle, investigated in PDM-ProValue and similarly recommended by the 2018 ADA/EASD consensus report, can benefit diabetes management in persons with type 2 diabetes. This is reflected in improved glycaemic control as well as patient and physician communication and satisfaction.